Clinical trial
Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study
NCT06053203 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study
- Lead sponsor
- Washington University School of Medicine
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2023
- Completion date
- November 30, 2024
- Enrollment
- 1,200 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hypertensive disorders of pregnancy